We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » China Approves 17 Cancer Drugs for National Health Insurer
China Approves 17 Cancer Drugs for National Health Insurer
China’s State Medical Insurance Administration approved 17 cancer drugs for inclusion in the country’s national health insurance system with deeply discounted prices.
To View This Article:
Login
Subscribe To International Pharmaceutical Regulatory Monitor